MAMTA SAPRA
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Geriatric Psychiatry SALEM, VA NPI 1881893071
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Geriatric Psychiatry VA Avanir Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$1,179.31
- Category: General Payments
- Program years: PY2019
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $1,179.31 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,004.31 | 4 |
| Food and Beverage | $175.00 | 4 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Avanir Pharmaceuticals, Inc. | $1,179.31 | 8 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2019 | $1,179.31 | 8 |
Records — PY2019 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 653612115 | Avanir Pharmaceuticals, Inc. | $30.00 | 08/23/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 653612117 | Avanir Pharmaceuticals, Inc. | $346.76 | 08/23/2019 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 653612119 | Avanir Pharmaceuticals, Inc. | $553.57 | 07/26/2019 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 653612121 | Avanir Pharmaceuticals, Inc. | $50.00 | 08/23/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 653612123 | Avanir Pharmaceuticals, Inc. | $51.99 | 08/22/2019 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 653612125 | Avanir Pharmaceuticals, Inc. | $51.99 | 08/23/2019 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 653612127 | Avanir Pharmaceuticals, Inc. | $65.00 | 08/23/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 653612129 | Avanir Pharmaceuticals, Inc. | $30.00 | 08/23/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.